This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International
September 22-25, 2026 as part of Biotech Week Boston
Hynes Convention CenterBoston, USA

Natalia Cherepanova
Senior Scientist II at Abbvie
Speaker

Profile

Natalia Cherepanova is a Senior Scientist II in Cell Line Development at AbbVie, where she leads efforts to develop new targeted integration–based CLD platforms. With more than 18 years of experience in cell biology, molecular biology, and cell line engineering, she supports initiatives to improve the productivity and robustness of AbbVie’s CLD process through innovative expression construct and platform design approaches. She leads a team of scientists, manages a flow cytometry team, and works cross-functionally across discovery and development. Natalia is also a recognized expert in protein N-glycosylation and DNA methylation, with more than 30 publications in the field. She holds a Ph.D. in Biochemistry from Moscow State University.

Agenda Sessions

  • Engineering Targeted Integration (TI) CLD platforms with multiple landing pads: lessons learned from landing pad configurations, vector design, and selection strategies

    9:00am